Bacil Pharma Limited (BOM:524516)
India
· Delayed Price · Currency is INR 43.70
+1.86 (4.45%)
At close: May 14, 2025
Bacil Pharma Revenue
In the fiscal year ending March 31, 2025, Bacil Pharma had annual revenue of 6.61M INR. Bacil Pharma had revenue of 877.00K in the quarter ending March 31, 2025.
Revenue
6.61M
Revenue Growth
n/a
P/S Ratio
90.17
Revenue / Employee
2.20M
Employees
3
Market Cap
596.37M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,553.24B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Bajaj Finance | 369.88B |